The Combination of High-Intensity Interval Aerobic and Resistance Training versus Current Recommendations in Patients with Type 2 Diabetes Mellitus

Not Applicable

Completed

• Conditions: Type 2 Diabetes Mellitus; Metabolic and Endocrine - Diabetes; Public Health - Health promotion/education

• Registration Number: ACTRN12615000475549
• Lead Sponsor: Trishan Gajanand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-14
• Study Completion: 2020-02-11
• Last Update Posted: 21 November 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 69

Inclusion Criteria

Male and female patients with type 2 diabetes mellitus aged 18-75 years will be included in this study. The diagnostic criteria for type 2 diabetes mellitus is confirmation of the disease from the patients’ medical doctor and either a fasting glucose level of 7.0 mmol/L or greater or a glycated haemoglobin level that is greater than 6.5%. Access to a smartphone or computer will be required.

Exclusion Criteria

Unstable angina; Recent (4 weeks) myocardial infarction; Coronary Artery Disease; Uncompensated heart failure; New York Heart Association (NYHA) Functional Classification II-IV; Severe valvular illness; Pulmonary disease; Uncontrolled hypertension (systolic blood pressure > 200 mmHg and/or diastolic blood pressure >110 mmHg); Renal failure (Chronic Kidney Disease stages III-V); Orthopaedic/neurological limitations; Cardiomyopathy; Planned operations during the research period; Physical impairment limiting the ability to exercise; Drug or alcohol abuse; Planning to or participation in another study; Not willing to sign the consent from; Females pregnant or expecting to be pregnant during the study period; Any other reason which would limit their ability to participate in this study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycated haemoglobin level (HbA1c).[Testing assessments will occur at baseline, 8 weeks, and 12 months for those initially randomised to one of the two exercise intervention groups while those initially randomised to the Waitlist Control group will have an additional testing period (i.e. baseline, 8 weeks, 16 weeks, and 14 months). ]